COVID19 vaccine (Vaxine)

N/A

Report date: 2026/04/14 20:00:15

Base Information

Drug NameCOVID19 vaccine (Vaxine)
Drug Alias NameCOVID19 recombinant spike protein with Advax-SM adjuvant (Vaxine)SARS-COV-2 Vaccine (Vaxine)
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus InfectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaIran
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesVaxine Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVaxine Pty LtdCinnagen
Inactive CompaniesGenecure Biotechnologies
Active IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Inactive IndicationsCoronavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A